glp 1 oral drug Structure Therapeutics GLP-1 Obesity Achieves 'Injectable-Like Efficacy' in Phase 2 Test Novo Nordisk's oral GLP-1 drug
Description
GLP-1 drugs can be used to treat chronic conditions caused by obesity and being overweight, but its essential to understand how they work
In the pancreas, GLP-1RAs are well known to promote insulin secretion
Its associated with modest weight loss
This is another important benefit of GLP-1s, as kidney disease is a common complication of diabetes
Characterization and role of glucagon-like peptide 1 receptor in the lacrimal gland: novel insights into diabetic Dry eye pathogenesis
In preclinical models of polymicrobial sepsis, such as the cecal slurry and cecal ligation puncture (CLP) models, long-acting GLP-1 receptor agonists (GLP-1RAs) like semaglutide have demonstrated protective effects
